Acute kidney injury in pregnancy on rise
March 31, 2020
Results of a very large cohort study underscore the need for routine screening of kidney function and detection of acute kidney injury in all women hospitalized during pregnancy.
Recent Content
Possible vertical transmission of coronavirus
March 30, 2020
A new research letter published in JAMA Network suggests that vertical transmission from mother to child may be possible while in utero.
Top 5 articles on how coronavirus impacts physicians
March 30, 2020
From physician health struggles to adapting care for patients to new safety measures, these articles illustrate how the coronavirus has affected the job of the physician.
Vasomotor symptoms and faster epigenetic aging
March 24, 2020
Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms but not during their reported menopause transition, according to new research.
Changes in hot flashes in women with breast cancer
March 24, 2020
A study in Menopause found that a significant proportion of premenopausal and perimenopausal women experienced hot flashes after receiving breast cancer treatment.
Family CVD history and decision-making about BSO
March 24, 2020
Some women proactively choose bilateral salpingo-oophorectomy (BSO) to minimize cancer risk, but new research indicates that for some women, the procedure may be doing more harm than good.
Opioids post-cesarean: Predicting use after discharge
March 24, 2020
Reviewing a patient’s intake of opioids after cesarean may help optimize pain management post-discharge, according to results of a new study.
‘Momnibus’ legislation aims to help black moms
March 20, 2020
A package of nine individual bills has just been introduced that aim to improve health for black mothers in the United States.
Timing twin delivery to optimize outcomes
March 20, 2020
Results of a new Scottish study suggest that delivery after 37 weeks’ gestation is optimal for uncomplicated twin pregnancies.
Does IUD type impact cervical cancer risk?
March 19, 2020
New research indicates that risk of high-grade cervical neoplasms is lower with copper (Cu) intrauterine devices (IUDs) than with the levonorgestrel-releasing intrauterine system (LNG-IUS).
